[HTML][HTML] Current update on nanoplatforms as therapeutic and diagnostic tools: A review for the materials used as nanotheranostics and imaging modalities
In the last decade, the use of nanotheranostics as emerging diagnostic and therapeutic tools
for various diseases, especially cancer, is held great attention. Up to date, several …
for various diseases, especially cancer, is held great attention. Up to date, several …
[HTML][HTML] Recent advances of lanthanide nanomaterials in Tumor NIR fluorescence detection and treatment
Q Fan, C Sun, B Hu, Q Wang - Materials Today Bio, 2023 - Elsevier
Lanthanide nanomaterials have garnered significant attention from researchers among the
main near-infrared (NIR) fluorescent nanomaterials due to their excellent chemical and …
main near-infrared (NIR) fluorescent nanomaterials due to their excellent chemical and …
Chiral protein supraparticles for tumor suppression and synergistic immunotherapy: an enabling strategy for bioactive supramolecular chirality construction
The design of bioactive supramolecular chirality is always hampered by the lack of feasible
schemes to assigned specific biological activities. Herein, we developed a “mirror-image …
schemes to assigned specific biological activities. Herein, we developed a “mirror-image …
[HTML][HTML] Nanoparticle delivery of miR-21-3p sensitizes melanoma to anti-PD-1 immunotherapy by promoting ferroptosis
W Guo, Z Wu, J Chen, S Guo, W You… - … for immunotherapy of …, 2022 - ncbi.nlm.nih.gov
Background Although anti-programmed cell death protein 1 (PD-1) immunotherapy is
greatly effective in melanoma treatment, low response rate and treatment resistance …
greatly effective in melanoma treatment, low response rate and treatment resistance …
[HTML][HTML] Turing milk into pro-apoptotic oral nanotherapeutic: De novo bionic chiral-peptide supramolecule for cancer targeted and immunological therapy
W He, Z Zhang, W Yang, X Zheng, W You, Y Yao… - Theranostics, 2022 - ncbi.nlm.nih.gov
Chirality in biomolecules is ubiquitous in our world, but oral nanomedicines constructed from
chiral peptides are extremely rare, principally because of the immature nanofabrication and …
chiral peptides are extremely rare, principally because of the immature nanofabrication and …
[HTML][HTML] A de novo dual-targeting supramolecular self-assembly peptide against pulmonary metastasis of melanoma
Despite recent advances in treatment, overall survival rates for metastatic melanoma,
especially those that invade the lungs, continue to be low, with 5-year survival rates of only …
especially those that invade the lungs, continue to be low, with 5-year survival rates of only …
Multistage tumor microenvironment-responsive theranostic nanopeanuts: toward multimode imaging guided chemo-photodynamic therapy
X Jing, Z Zhi, N Zhang, H Song, Y Xu, G Zhou… - Chemical Engineering …, 2020 - Elsevier
It is of great importance to develop tumor microenvironment (TME) responsive and
adjustable theranostic nano-systems for specific and efficient cancer treatment. However …
adjustable theranostic nano-systems for specific and efficient cancer treatment. However …
A Tumor‐Targeting Metal‐Organic Nanoparticle Constructed by Dynamic Combinatorial Chemistry toward Accurately Redressing Carcinogenic Wnt Cascade
Targeted and immunological therapy have revolutionized the malignancy treatment, but is
suffering from the dose‐limiting side effects and inadequate responsiveness. The emerging …
suffering from the dose‐limiting side effects and inadequate responsiveness. The emerging …
De novo Nano‐erythrocyte structurally braced by biomimetic Au (I)‐peptide skeleton for MDM2/MDMX predation toward augmented pulmonary adenocarcinoma …
In nature, cells rely on a structural framework called the “cytoskeleton” to maintain their
shape and polarity. Based on this, herein a new class of cell‐mimicking nanomedicine using …
shape and polarity. Based on this, herein a new class of cell‐mimicking nanomedicine using …
Resurrecting a p53 peptide activator-An enabling nanoengineering strategy for peptide therapeutics
Many high-affinity peptide antagonists of MDM2 and MDMX have been reported as
activators of the tumor suppressor protein p53 with therapeutic potential. Unfortunately …
activators of the tumor suppressor protein p53 with therapeutic potential. Unfortunately …